Developed a patent portfolio for international biotechnology company that contained over 75 patent families, including applications and patents to protect tools for target identification and validation, novel therapeutic targets, as well as vaccine-based and antibody-based therapeutics directed to those targets. Technology was one of the first applications of bioinformatics for target identification. It was the key intellectual property for this division of the company.